benfotiamine
PolandDrugs containing this active substance
-
The medicinal product is used to prevent the effects of and treat the consequences of vitamin B deficiency in the body. This deficiency may result from improper nutrition, intensive dieting, hemodialysis, or chronic alcoholism.
Form: tablets, coated
Active substance Dosage benfotiamine 50 mg ATC: A11DA03
Manufacturer: Woerwag Pharma Production GmbH & Co. KG
-
The medicine is used to treat confirmed vitamin B deficiency, to prevent the effects of this deficiency in persons at risk, and to treat neuropathy and cardiovascular disorders caused by vitamin B deficiency.
Form: tablets, film-coated
Active substance Dosage benfotiamine 300 mg ATC: A11DA03
Manufacturer: Dragenopharm Apotheker Pueschl GmbH
-
The medicinal product is used as supportive treatment for, among others, neurological disorders of an inflammatory nature (neuritis), nerve pain (neuralgia), including those caused by diabetes or alcoholism, migraine, painful muscle strains, radiculitis, cervical or brachial neuralgia, herpes zoster, and facial nerve paralysis. It is also indicated for elderly patients and during convalescence.
Form: tablets, film-coated
Active substance Dosage benfotiamine 40 mg pyridoxine hydrochloride 90 mg cyanocobalamin 0.25 mg ATC: A11DB01
Manufacturer: Mako Pharma Sp. z o.o.
-
It is used to treat confirmed vitamin B deficiency, to prevent this deficiency in persons at risk, and to treat neuropathy caused by the lack of this vitamin.
Form: tablets
Active substance Dosage benfotiamine 300 mg ATC: A11DA03
Manufacturer: Mako Pharma Sp. z o.o.
-
The medicinal product is used as adjuvant therapy in peripheral nerve disorders, such as polyneuropathy, peripheral neuritis, and neuralgia. It contains B vitamins, which support nerve cell metabolism and stimulate their regeneration.
Form: tablets, film-coated
Active substance Dosage benfotiamine 150 mg pyridoxine hydrochloride 50 mg cyanocobalamin 0.2 mg ATC: A11DB
Manufacturer: Adamed Pharma S.A.
-
The medicinal product is used in the treatment of nervous system diseases caused by a documented deficiency of vitamin B1 and B6.
Form: tablets
Active substance Dosage benfotiamine 100 mg pyridoxine hydrochloride 100 mg ATC: A11DB
Manufacturer: Mauermann – Arzneimittel KG
-
The medicinal product is used in the treatment of nervous system diseases caused by a documented deficiency of vitamin B1 and B6.
Form: tablets, coated
Active substance Dosage benfotiamine 100 mg pyridoxine hydrochloride 100 mg ATC: A11DB
Manufacturer: Woerwag Pharma GmbH & Co. KG
-
The medicine is used to treat vitamin B1 deficiency that cannot be compensated for by diet alone. This may be caused by an insufficient amount of vitamin in food, poor absorption, or increased body requirements (e.g., in cases of diabetes, pregnancy, breastfeeding, or excessive alcohol consumption).
Form: tablets, film-coated
Active substance Dosage benfotiamine 50 mg ATC: A11DA03
Manufacturer: G.L. Pharma GmbH
-
The medicine is used to treat vitamin B1 deficiency that cannot be compensated for by diet alone. This may be caused by a lower amount of vitamin in food, poor absorption, or increased body requirements (e.g., in diabetes, alcohol consumption, or during pregnancy and breastfeeding).
Form: tablets, film-coated
Active substance Dosage benfotiamine 300 mg ATC: A11DA03
Manufacturer: G.L. Pharma GmbH
-
The medicinal product is used in adults for the treatment of peripheral nerve diseases (neuropathies) resulting from a deficiency of vitamin B1 and vitamin B6.
Form: tablets, film-coated
Active substance Dosage benfotiamine 100 mg pyridoxine hydrochloride 100 mg ATC: A11DB
Manufacturer: G.L. Pharma GmbH
-
The medicinal product is used for the treatment of confirmed deficiency of vitamins B1, B6, and B12 in adults, and for the prevention or treatment of nerve diseases, such as polyneuropathy.
Form: tablets, film-coated
Active substance Dosage benfotiamine 40 mg pyridoxine hydrochloride 90 mg cyanocobalamin 0.25 mg ATC: A11DB
Manufacturer: G.L. Pharma GmbH